Alnylam Pharmace. buy WatchMen
Start price
16.10.19
/
50%
€73.50
Target price
09.02.20
-
Performance (%)
54.50%
End price
09.02.20
€113.56
Summary
This prediction ended on 09.02.20 with a price of €113.56. With a performance of 54.50% the BUY prediction by WatchMen was a big success. WatchMen has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 4.034% | 4.034% | -48.106% | 18.712% |
| iShares Core DAX® | 0.437% | 5.640% | 7.806% | 63.642% |
| iShares Nasdaq 100 | 1.057% | 0.282% | 27.239% | 88.123% |
| iShares Nikkei 225® | 1.769% | 0.406% | 49.266% | 83.527% |
| iShares S&P 500 | 0.368% | 1.920% | 22.336% | 68.755% |
Comments by WatchMen for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.